| Income Statement |
| Total Revenue | 1.85M |
|
| Revenues (USD) | 1.85M |
| Cost of Revenue | 304.00K |
| Gross Profit | 1.55M |
| Operating Expenses | 4.67M |
| Research and Development Expense | 2.06M |
| Selling, General and Administrative Expense | 2.61M |
| Operating Income | -3.12M |
| Interest Expense | 255.00K |
| Income Tax Expense | 64.00K |
| Net Income | -3.44M |
| Net Income Common Stock | -3.44M |
| Net Income Common Stock (USD) | -3.44M |
| Consolidated Income | -3.44M |
| Earnings per Basic Share | -0.26 |
| Earnings per Basic Share (USD) | -0.26 |
| Earnings per Diluted Share | -0.26 |
| Earning Before Interest & Taxes (EBIT) | -3.12M |
| Earning Before Interest & Taxes (USD) | -3.12M |
| Weighted Average Shares | 13.39M |
| Weighted Average Shares Diluted | 13.79M |
| Balance Sheet |
| Cash and Equivalents | 818.00K |
| Cash and Equivalents (USD) | 818.00K |
| Trade and Non-Trade Receivables | 568.00K |
| Current Assets | 1.98M |
| Property, Plant & Equipment Net | 554.00K |
| Total Assets | 2.63M |
| Debt Current | 2.40M |
| Total Debt | 2.49M |
| Current Liabilities | 13.85M |
| Debt Non-Current | 95.00K |
| Total Liabilities | 14.63M |
| Accumulated Retained Earnings (Deficit) | -61.58M |
| Shareholders Equity | -12.00M |
| Shareholders Equity (USD) | -12.00M |
| Assets Non-Current | 653.00K |
| Total Debt (USD) | 2.49M |
| Deferred Revenue | 4.14M |
| Liabilities Non-Current | 778.00K |
| Trade and Non-Trade Payables | 2.02M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 15.00K |
| Net Cash Flow from Financing | -60.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.48M |
| Capital Expenditure | -23.00K |
| Issuance (Repayment) of Debt Securities | -60.00K |
| Net Cash Flow from Investing | -23.00K |
| Net Cash Flow from Operations | -2.40M |
| Effect of Exchange Rate Changes on Cash | -17.00K |
| Share Based Compensation | 223.00K |